New treatment option for Ankylosing Spondylitis
Official title Taekwondo for Axial Spondyloarthritis
ClinicalTrials.gov ID: NCT06823726
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if Taekwondo training works to help adults with ankylosing spondylitis and axial spondyloarthritis. It will also learn about the safety of Taekwondo training for these adults.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 59
You may be able to join if
- Diagnosed with axial spondyloarthritis (axSpA) according to the ASAS classification criteria.
- Age: Between 19 and 59 years old.
- Stable medication or non-medication treatment:
- Patients whose medication regimen has remained stable for at least the past 3 months.
- Patients who have not taken medication for axSpA for at least the past 3 months.
You likely can't join if
- Participants will be excluded from the study if they meet any of the following conditions:
- History of orthopedic surgery or fractures within the past 12 months.
- History of cardiovascular diseases, including ischemic heart disease, cardiomyopathy, heart failure, or stroke.
- Advanced ankylosis in ankylosing spondylitis, as confirmed by radiographic or CT imaging: \- Complete ankylosis of at least two regions of the...
- Presence of other musculoskeletal abnormalities or conditions that may limit exercise performance.
- Diagnosis of cancer within the past 5 years
See the full eligibility criteria
- Diagnosed with axial spondyloarthritis (axSpA) according to the ASAS classification criteria.
- Age: Between 19 and 59 years old.
- Stable medication or non-medication treatment:
- Patients whose medication regimen has remained stable for at least the past 3 months.
- Patients who have not taken medication for axSpA for at least the past 3 months.
- Participants will be excluded from the study if they meet any of the following conditions:
- History of orthopedic surgery or fractures within the past 12 months.
- History of cardiovascular diseases, including ischemic heart disease, cardiomyopathy, heart failure, or stroke.
- Advanced ankylosis in ankylosing spondylitis, as confirmed by radiographic or CT imaging: \- Complete ankylosis of at least two regions of the cervical, lumbar, or thoracic spine (i.e., continuous syndesmophyte...
- Presence of other musculoskeletal abnormalities or conditions that may limit exercise performance.
- Diagnosis of cancer within the past 5 years
- Pregnancy
- Regular exercise participation within the past 6 months (defined as exercising for at least 60 minutes per session, three or more times per week).
- Major changes in medication for axial spondyloarthritis during the study period, including:
- Initiation or discontinuation of biologic agents or targeted therapies.
- Significant changes in the continued use of NSAIDs or sulfasalazine.
- Significant changes in the continued use of systemic glucocorticoids.
The study team makes the final eligibility decision.
Where it's taking place
- Wŏnju, Gangwon-do, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wŏnju, Gangwon-do, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.